Enterovirus 71 (EV71) is the major etiological agent of hand, foot, and mouth disease (HFMD). Early studies showed that EV71-infected patients with severe complications exhibited elevated plasma levels of IL-1b, indicating that EV71 may activate inflammasomes. Our current study demonstrates that the NLRP3 inflammasome plays a protective role against EV71 infection of mice in vivo. EV71 replication in myeloid cells results in the activation of the NLRP3 inflammasome and secretion of IL-1b. Conversely, EV71 counteracts inflammasome activation through cleavage of NLRP3 by viral proteases 2A and 3C, which cleave NLRP3 protein at the G493-L494 or Q225-G226 junction, respectively. Moreover, EV71 3C interacts with NLRP3 and inhibits IL-1b secretion when expressed in mammalian cells. These results thus reveal a set of reciprocal regulations between enterovirus 71 and the NLRP3 inflammasome.
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INTRODUCTION
Since its first identification in 1969, enterovirus 71 (EV71) has caused many epidemics in the world, especially in the Asia-Pacific region, manifested by hand, foot, and mouth disease (HFMD) (Huang et al., 2012) . Infection with EV71 can lead to severe neurological complications such as encephalitis, acute flaccid paralysis, and pulmonary edema in children . EV71 belongs to the genus Enterovirus within the Picornaviridae family, which is a non-enveloped virus with a single positive-stranded RNA genome. The genome encodes a single polyprotein precursor that gets processed into mature proteins by viral-encoded proteases 2A and 3C . These proteases also cleave host factors to dampen immune responses. For example, 3C cleaves TRIF, IRF7, and IRF9 to inhibit innate immune responses (Hung et al., 2011; Lei et al., 2011 Lei et al., , 2013b ; 2A inhibits interferon responses by cleaving interferon receptor (IFNAR) and MAVS (Lu et al., 2012; Wang et al., 2013a) .
Although EV71 utilizes various approaches to control immune responses, the mammalian host can still mount an effective defense against infection of this virus. Several studies showed that EV71-infected patients, particularly those with neurologic complications, carried elevated levels of cytokines and chemokines, including interleukin-1b (IL-1b), IL-6, and IL-8 (Bek and McMinn, 2010; Griffiths et al., 2012; Lin et al., 2003) . Upon EV71 infection, human-monocyte-derived macrophages produce proinflammatory cytokines IL-1b, IL-6, and tumor necrosis factor a (TNF-a), although peripheral blood mononuclear cells (PBMCs) from patients with pulmonary edema exhibit lower IL-1b and interferon-g (IFN-g) levels than PBMCs from individuals with mild symptoms (Chang et al., 2006; Gong et al., 2012) . These observations indicate that the inflammatory response induced by EV71 may involve the activation of inflammasomes.
The inflammasome is a multi-protein complex that senses infection or danger signals in the cell to control the maturation and secretion of the pleiotropic pro-inflammatory cytokines IL-1b and IL-18. To date, several inflammasomes have been identified, of which the NLRP3 inflammasome is the most extensively studied (Lamkanfi and Dixit, 2014) . Upon activation, NLRP3 oligomerizes via homotypic interactions between NACHT domains and thereby presents clustered Pyrin domains for interaction with the Pyrin domain of ASC. Clustered ASC in turn recruits pro-caspase-1 via the CARD-CARD interaction and induces proximity-induced auto-cleavage of caspase-1 (Lu et al., 2014) . Activated caspase-1 tetramer cleaves a wide range of proteins involved in various functions such as cell death and non-canonical protein secretion (Keller et al., 2008) . NLRP3 inflammasome senses a plethora of pathogens and danger-associated molecular patterns (DAMPs), including environmental irritants, endogenous danger signals, and alum adjuvants (Schroder et al., 2010) . Sendai virus and influenza A virus are the first reported viruses that activate the NLRP3 inflammasome (Kanneganti et al., 2006) . Subsequent studies have shown that modified vaccinia virus ankara (MVA), encephalomyocarditis virus (EMCV), and adenovirus can also induce IL-1b secretion in an NLRP3-dependent manner (Barlan et al., 2011; Delaloye et al., 2009 ).
Our present study reveals that the NLRP3 inflammasome plays a protective role against EV71 infection in vivo. Furthermore, we found that EV71 proteases 2A and 3C regulate inflammasome activity through cleavage of NLRP3. Our results thus shed light on the physiopathologic relevance of the NLRP3 inflammasome during EV71 infection, which may provide therapeutic targets for anti-EV71 treatment.
RESULTS
The NLRP3 Inflammasome Protects Mice from EV71 Infection To investigate the potential involvement of inflammasome against EV71 infection, infant mice were infected with EV71 virus through intracerebral injection to mimic neurological infection (Figure 1 ). In this experiment, phenotypes of C57BL/6-background mice deficient for NLRP3, ASC, or caspase-1 were compared with C57BL/6 wild-type (WT) mice. Since C57BL/6 mice are more resistant to EV71 infection than ICR mice, we observed only a low level of death (data not shown). However, it was obvious that NLRP3-, ASC-, and caspase-1-deficient mice clearly exhibited more severe disease than WT mice according to a scoring method ( Figure 1A ). The mice deficient for NLRP3 inflammasome showed earlier occurrence of disease, stronger paralysis, and delayed recovery compared with WT animals. The morbidity rates of these gene-deficient mice were also higher than those of WT control mice ( Figure 1B) .
It is known that inflammasome activation is required for secretion of mature IL-1b, which is not only a pyrogen by itself but also a potent inducer of many pro-inflammatory cytokines and chemokines (Dinarello, 2011) . Consistent with this, brain tissue from NLRP3-inflammasome-deficient mice contained not only a lower level of IL-1b but also decreased amounts of IL-6, TNF-a, and IFN-g as compared with WT control at early time point (2 days) postinfection ( Figures 1C and S1A ). With disease progression, the mice developed lameness in their hindlegs. H&E staining of hindleg femur muscle from mice 9 days after infection revealed that NLRP3-inflammasome-deficient animals carried more severe necrotizing myositis and stronger inflammatory cell infiltration ( Figures 1D and S1B ). At this stage, the expression of inflammatory cytokines and chemokines was also higher in the muscle of mice deficient for NLRP3, ASC, or caspase-1 than in WT mice ( Figures 1E and S1C ). Accordingly, there was higher EV71 viral load in these deficient mice in the brain 9 days after infection ( Figure 1F ). These data thus indicate that the NLRP3 inflammasome plays a protective role against EV71 infection in mice.
EV71 Infection Induces IL-1b Secretion in Myeloid Cells
To explore whether EV71 activates the NLRP3 inflammasome in vitro, we infected human monocytic cell line THP-1 cells with EV71 virus. A dose-dependent IL-1b secretion was detected in the supernatant (Figure 2A ). Accordingly, increased expression of EV71 VP0 and VP2 proteins was detected in the cell lysates, indicating an active viral replication ( Figure 2B ). Time-course assays also showed increased secretion of IL-1b and IL-18 ( Figures  2C and 2D ). Viral titer in the supernatant increased accordingly ( Figure S2A ). Moreover, EV71 infection of THP-1-derived macrophages, human monocytic cell line Mono Mac 6 cells, primary human PBMCs, and mouse bone-marrow-derived dendritic cells (BMDCs) also resulted in IL-1b secretion, indicating that EV71
activates the inflammasome to stimulate mature IL-1b secretion . These results indicate that infection with EV71 causes IL-1b secretion in myeloid cells in both humans and mice. To establish infection, EV71 enters host cells through clathrindependent endocytosis (Hussain et al., 2011) . We found that two clathrin-dependent endocytosis inhibitors, dynamin inhibitory peptide (DIP) and chlorpromazine (CPZ), inhibited EV71-mediated IL-1b production ( Figure S2C ), indicating that EV71 entry was required for IL-1b induction. Rupintrivir, an EV71 replication inhibitor, also inhibited EV71-induced IL-1b secretion (Figure S2D) . Finally, UV rays or heat-inactivated EV71 virus failed to replicate or induce IL-1b secretion in THP-1 cells ( Figures  2H, 2I , and S2E). Together, these results indicate that EV71 entry and replication are required for IL-1b secretion.
EV71 Infection Activates the NLRP3 Inflammasome
Since caspase-1 activation and ASC oligomerization are the direct indicators for inflammasome activation , we examined the caspase-1 cleavage and ASC pyroptosome formation in EV71-infected THP-1 cells. As shown in Figures 3A and 3B, mature caspase-1 and IL-1b were detected in the supernatant and ASC oligomer was formed after EV71 infection. Lipopolysaccharide (LPS) served as a positive control in this experiment.
Moreover, we found that the inhibitor of caspase-1 AC-YVAD-CHO strongly decreased EV71-induced IL-1b secretion, indicating that EV71-induced IL-1b secretion was caspase-1 dependent ( Figure 3C ). In addition, high-concentration K + treatment blocked EV71-induced IL-1b secretion ( Figure 3D ). Furthermore, the NLRP3 inhibitor glibenclamide (glyburide) also inhibited EV71-induced IL-1b production ( Figure 3E ). To directly assess the involvement of the NLRP3 inflammasome in EV71-induced IL-1b secretion, we transfected small interfering RNAs (siRNAs) to silence the expression of ASC, NLRP3, and caspase-1 in THP-1 cells before EV71 infection ( Figure S3A ). EV71-induced IL-1b secretion, but not inflammasome-independent IL-8 production from knockdown cells, was clearly decreased ( Figures  3F and S3B) . Similar results were obtained in ASC-or NLRP3-deficient THP-1 cells ( Figures 3G and S3C) . Furthermore, these findings were confirmed with BMDCs from WT, Nlrp3
deficient for NLRP3 inflammasome exhibited decreased secretion of IL-1b compared with WT cells (Figure 3H ), while TNF-a production was not changed ( Figure S3D ). Taken together, these data indicate that EV71 infection activates the NLRP3 inflammasome and that the activity of NLRP3 is required for EV71-induced IL-1b secretion.
EV71 Proteases 2A and 3C Cleave NLRP3 and Inhibit NLRP3 Inflammasome Activation We noticed that in NLRP3-, ASC-, and caspase-1-knockdown THP-1 cells, EV71 replication was more active, as indicated by higher viral titers in the supernatants ( Figure S4A ). A similar result was observed in NLRP3-or ASC-deficient THP-1 cells (Figure S4B ). These data indicated that the NLRP3 inflammasome was required for the control of EV71 replication, which was consistent with our in vivo study (Figure 1) . On the contrary, EV71 has evolved approaches to dodge or counteract the host immune response to establish infection (Hung et al., 2011; Lei et al., 2011 Lei et al., , 2013b Lu et al., 2012; Wang et al., 2013a) . To investigate whether EV71 3C or 2A can target NLRP3 via cleavage, recombinant 3C and 2A proteases were purified and incubated with 293T cell extracts expressing NLRP3. The 3C and 2A proteases cleaved NLRP3 protein, producing a 90-kDa or 65-kDa fragment, respectively ( Figure 4A ). An immunoprecipitation assay confirmed the interaction between NLRP3 and 3C when co-transfected in 293T cells ( Figure S4C ). To define the cleavage site, we generated a series of human NLRP3 mutants. The mutants Q250A, Q269A, Q303A, and Q323A were still cleaved by the 3C protease ( Figure 4B ). However, the Q225A mutant was resistant to cleavage by 3C (lane 4, Figure 4B ), suggesting the Q225-G226 pair is a cleavage site for 3C. Mouse NLRP3 also carries this cleavage site ( Figure S4D ) and can be cleaved by 3C ( Figure S4E) . Moreover, the cleavage was NLRP3 specific, since AIM2, ASC, caspase-1, and IL-1b were not cleaved by 3C ( Figure S4F ). Similarly, we identified the G493-L494 pair as the cleavage site for 2A ( Figure 4D ).
Since 3C cleaves NLRP3, it may also inhibit the activation of the NLRP3 inflammasome. To address this issue, 293T cells were transiently transfected with plasmids expressing NLRP3, ASC, pro-capase-1, and pro-IL-1b (Komune et al., 2011) . It was shown that 3C expression dose-dependently reduced IL-1b secretion from 293T cells reconstituted with the NLRP3 inflammasome (Figure 4C) . The cleavage of NLRP3 was correlated with 3C expression ( Figure S4G ). Furthermore, EV71 viral infection cleaved ectopic-expressed human and mouse NLRP3 in 293T cells (Figure 4E) . Importantly, the cleavage fragments 225-N and 225-C decreased IL-1b secretion induced by LPS in THP-1 cells compared to WT-NLRP3 ( Figure S4H ). Moreover, expression of the cleavage-resistant Q225A mutant of NLRP3 led to clearly elevated induction of IL-1b upon EV71 infection ( Figure 4F ). In addition, expression of 3C in THP-1 macrophages inhibited IL-1b secretion induced by nigericin, but not poly(dA:dT) (Figure 4G ), indicating that AIM2 was not targeted by 3C. Moreover, the protease activity of EV71-3C is necessary for the cleavage of NLRP3, as the 3C protease inhibitor rupintrivir, but not the caspase inhibitor Z-VAD or the proteasome inhibitor MG132, blocked 3C-mediated NLRP3 cleavage ( Figure S4I ). It is known that H40D or C147S substitution of 3C protein abrogates protease activity and that R84Q or V154S substitution affects its RNA binding activity. From our mutational analysis, it was found that WT 3C led to NLRP3 cleavage and resulted in the inhibition of IL-1b secretion ( Figures 4H and 4I ). However, H40D and C147S were unable to induce NLRP3 cleavage or to inhibit IL-1b secretion. In contrast, R84Q and V154S mutation was still functioning as WT-3C ( Figures  4H and 4I ). Taken together, these data show that EV71 3C cleaves NLRP3 to inhibit NLRP3-mediated IL-1b secretion and that 3C protease activity plays a critical role in this process.
DISCUSSION
Although progress has been made in EV71 research since its identification, a knowledge gap exists with respect to the host immune responses against EV71 infection. Here, we demonstrate that the NLRP3 inflammasome plays a protective role against EV71 infection. At an early time point after EV71 challenge, NLRP3-inflammasome-deficient mice showed decreased IL-1b secretion, which should be due to the lack of inflammasome activity. Moreover, the levels of other pro-inflammatory cytokines such as IFN-g, TNF-a, and IL-6 were also lower in mice deficient for NLRP3 inflammasome compared with that in WT mice. This was probably caused indirectly by the decrease of IL-18 and IL-1b in these animals. At a later time point after EV71 infection, mice deficient for the NLRP3 inflammasome exhibited uncontrolled viral replication and elevated levels of pro-inflammatory cytokines and chemokines. This indicates that inflammasome activity is critical for the control of EV71 via initiation of an effective inflammatory response at an early time point after infection. Once EV71 establishes infection and amplifies in the host, it causes inflammation in tissues such as brain and muscle, leads to damage of these tissues in an inflammasome-independent manner, and results in pathogenesis and death. Thus, the inflammasome-dependent response early after EV71 infection seems to be beneficial to the host, while the inflammasome-independent overwhelming inflammation at a later time point is deleterious in our mouse model. Therefore, fine-tuning inflammasome activity may be helpful to control EV71 infection. Enterovirus 71 belongs to Picornaviruses family, which is a large family of fast-evolving small RNA viruses including many important human and animal pathogens (Tapparel et al., 2013) . As an important arm of innate immune defense, the NLRP3 inflammasome is not only critical for the control of EV71 infection, as revealed in the present study, but also involved in responses to other picornaviruses, as implied from early studies. EMCV viroporin 2B and rhinovirus ion channel protein 2B were both able to activate the NLRP3 inflammasome in cultured cells (Ito et al., 2012; Triantafilou et al., 2013) . Thus, based on our current finding that the NLRP3 inflammasome is protective against EV71 infection, it is reasonable to speculate that it may also play a protective role against other picornaviruses.
Intriguingly, we find that EV71 not only activates the NLRP3 inflammasome but also inhibits inflammasome activation through cleavage of NLRP3. On the one hand, this is not surprising, because many pathogens are sensed by host innate immune system, and they also have regulatory machinery to avoid or inhibit immune responses (Taxman et al., 2010) ; on the other hand, this makes it hard to understand the kinetics of inflammasome activation versus inhibition upon EV71 infection. Probably, at the early phase of infection, RNA and proteins from EV71 induce NLRP3 protein expression and inflammasome assembly. When the virus replicates and generates enough 3C and 2A proteases at the later phase of infection, NLRP3 gets cleaved and inflammasome activity is harnessed. There should be overlapping time between these two phases. In fact, NLRP3 inflammasome activation by EV71 infection is much slower and weaker than that from bacterial or fungal infections Mariathasan et al., 2006) . It is known that pathogens can use either competitive protein homologs or their toxic proteins to bind and inactivate inflammasome proteins (Gregory et al., 2011; LaRock and Cookson, 2012; Taxman et al., 2010) . Here, we discovered a mechanism for the viral regulation of inflammasome, which is that the viral proteases cleave NLRP3 as an anti-inflammasome tactic. This may be a prevalent mechanism of various enteroviruses to combat NLRP3 inflammasome activity.
EXPERIMENTAL PROCEDURES Mice
Asc-and Nlrp3-deficient mice have been described before (Mao et al., 2013; Mariathasan et al., 2004) . Caspase-1-deficient mice were from The Jackson Laboratory and crossed onto the C57BL/6 genetic background for ten generations. Animal care and use and experimental procedures complied with national guidelines and were approved by the animal care and use committee at Institut Pasteur of Shanghai.
Statistics
Statistical evaluation between control and experimental samples was performed using the Student's t test. p values < 0.05 were considered significant (***p < 0.001, **p < 0.01, and *p < 0.05).
Detailed experimental procedures are included in Supplemental Experimental Procedures.
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